For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.
- AV access thrombosis
- Arteriovenous fistula (AVF)
- Arteriovenous graft (AVG)
- Pulse spray aided pharmacomechanical thrombolysis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine